A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : eCB / endogenous cannabinoid

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   eCB  (>> Co-occurring Abbreviation)
Long Form:   endogenous cannabinoid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 2-AG and anandamide enhance hippocampal long-term potentiation via suppression of inhibition. 2-AG, fEPSPs, LTP, TBS
2022 Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease. PD
2021 Depolarization-initiated endogenous cannabinoid release and underlying retrograde neurotransmission in interneurons of amygdala. DSE, LA
2021 Endocannabinoid reactivity to acute stress: Investigation of the relationship between salivary and plasma levels. 2-AG, AEA
2021 Endocannabinoids, cannabinoids and the regulation of anxiety. CB1
2021 Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior. 5-CSRTT, CB1R, LHb, SUDs
2021 Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models. 2-AG, AUD, DAGL
2020 Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior. 2-AG, LTD, mGluR5, MSNs, NAc
2020 Monoacylglycerol lipase alpha inhibition alters prefrontal cortex excitability and blunts the consequences of traumatic stress in rat. 2-AG, E/I, IS, MAGL, vmPFC
10  2019 Elevated Levels of Arachidonic Acid-Derived Lipids Including Prostaglandins and Endocannabinoids Are Present Throughout ABHD12 Knockout Brains: Novel Insights Into the Neurodegenerative Phenotype. 2-AG, AA, ABHD12, AEA, KO, PGs, PHARC, WT
11  2019 Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder. AUD, BNST, EA
12  2019 The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review. CBD, SUDs
13  2018 Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain. 2-AG, COX-2, PG-Gs
14  2018 Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. CDFA, dBNST
15  2018 Integrating endocannabinoid signaling in the regulation of anxiety and depression. ---
16  2018 The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. AEA, FAAH, OEA, PEA
17  2017 Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype. CeA, CRF, CRF1, FAAH, msP
18  2017 Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. 2-AG
19  2016 Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model. 2-AG, MAGL
20  2016 Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation. LTP, PUFAs
21  2015 Acute and chronic ethanol exposure differentially regulate CB1 receptor function at glutamatergic synapses in the rat basolateral amygdala. BLA, CIE
22  2015 Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex. 2-AG, LTD, mAChR, MAGL, PFC
23  2015 Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. 2-AG, LTP, MAGL
24  2014 Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. FAAH
25  2014 Comparative effects of pulmonary and parenteral Delta⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats. CPA, FAAH
26  2014 Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. AA, COX-2, FAAH, MAGL, PG, SSCIs
27  2013 No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample. BD, CNR1, FAAH, NAPE-PLD, tSNPs
28  2013 Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. COX-2
29  2012 Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats. LFPs, NAc, PR
30  2011 Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats. CB1, CORT, HPA
31  2010 Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis. alBNST, BNST, CB1, VGLUT1
32  2009 Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis. CBR, HPLC
33  2009 FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats. ---
34  2008 Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. SUD
35  2007 Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. AC, CB1R, LTD, PFC, PKA
36  2005 Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. ---
37  2005 Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell. DGCs, DSI, IPSC
38  2004 Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. ---